January 14, 2020

Idera Pharmaceuticals Provides 2020 Update and Outlook

Idera Pharmaceuticals is providing an update on its tilsotolimod clinical development program and a corporate outlook for 2020.
December 23, 2019

Idera Confirms Private Placement of up to US$97.7 Million

Idera Pharmaceuticals announced today it is entering into an agreement for gross proceeds of US$3.9 million.